Concepedia

Publication | Closed Access

Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement.

32

Citations

0

References

2003

Year

John Bogdanos, Dimitrios Karamanolakis, Constantine Milathianakis, Panayiotis Repousis, A Tsintavis, Michael Koutsilieris
PubMed

Abstract

Our data suggest that rHuEPO-beta correctable CAB-induced anemia occurs in 14.3% of prostate cancer patients after 6 months of therapy.